Literature DB >> 30282770

Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality.

Karen C Albright1, Lei Huang2, Justin Blackburn2, George Howard2, Michael Mullen2, Vera Bittner2, Paul Muntner2, Virginia Howard2.   

Abstract

OBJECTIVE: To determine black-white differences in 1-year recurrent stroke and 30-day case fatality after a recurrent stroke in older US adults.
METHODS: We conducted a retrospective cohort study using a 5% random sample of Medicare beneficiaries with fee-for-service health insurance coverage who were hospitalized for ischemic stroke between 1999 and 2013. Hazard ratios for recurrent ischemic stroke and risk ratios for 30-day case fatality comparing blacks to whites were calculated with adjustment for demographics, risk factors, and competing risk of death when appropriate.
RESULTS: Among 128,789 Medicare beneficiaries having an ischemic stroke (mean age 80 years [SD 8 years], 60.4% male), 11.1% were black. The incidence rate of recurrent ischemic stroke per 1,000 person-years for whites and blacks was 108 (95% confidence interval [CI], 106-111) and 154 (95% CI 147-162) , respectively. The multivariable-adjusted hazard ratio for recurrent stroke among blacks compared with whites was 1.36 (95% CI 1.29-1.44). The case fatality after recurrent stroke for blacks and whites was 21% (95% CI 21%-22%) and 16% (95% CI 15%-18%), respectively. The multivariable-adjusted relative risk for mortality within 30 days of a recurrent stroke among blacks compared with whites was 0.82 (95% CI 0.73-0.93).
CONCLUSION: The risk of stroke recurrence among older Americans hospitalized for ischemic stroke is higher for blacks compared to whites, while 30-day case fatality after recurrent stroke remains lower for blacks.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Year:  2018        PMID: 30282770      PMCID: PMC6251602          DOI: 10.1212/WNL.0000000000006467

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Differences in the role of black race and stroke risk factors for first vs. recurrent stroke.

Authors:  George Howard; Brett M Kissela; Dawn O Kleindorfer; Leslie A McClure; Elsayed Z Soliman; Suzanne E Judd; J David Rhodes; Mary Cushman; Claudia S Moy; Kara A Sands; Virginia J Howard
Journal:  Neurology       Date:  2016-01-20       Impact factor: 9.910

3.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

4.  Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama
Journal:  Stroke       Date:  2011-05-26       Impact factor: 7.914

5.  Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

Authors:  R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

6.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

7.  Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening.

Authors:  Katia Noyes; Hangsheng Liu; Jeffrey M Lyness; Bruce Friedman
Journal:  Psychiatr Serv       Date:  2011-10       Impact factor: 3.084

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

9.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

10.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

View more
  9 in total

1.  Exploring Factors Contributing to Race Differences in Poststroke Disability.

Authors:  Lesli E Skolarus; Chunyang Feng; James F Burke
Journal:  Stroke       Date:  2020-05-14       Impact factor: 7.914

2.  Ischemic stroke in patients with POEMS syndrome.

Authors:  Jun Feng; Xue-Min Gao; Hao Zhao; Tian-Hua He; Cong-Li Zhang; Kai-Ni Shen; Lu Zhang; Xin-Xin Cao; Ming Qian; Dao-Bin Zhou; Jian Li
Journal:  Blood Adv       Date:  2020-07-28

3.  Meta-Analysis of Randomized Clinical Trials Comparing the Impact of Implantable Loop Recorder Versus Usual Care After Ischemic Stroke for Detection of Atrial Fibrillation and Stroke Risk.

Authors:  Darae Ko; Qiying Dai; David B Flynn; Nicholas A Bosch; Robert H Helm; Kevin M Monahan; Charlotte Andersson; Christopher D Anderson; Allan J Walkey
Journal:  Am J Cardiol       Date:  2021-10-28       Impact factor: 2.778

4.  Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States.

Authors:  Lesli E Skolarus; Anjail Sharrief; Hannah Gardener; Carolyn Jenkins; Bernadette Boden-Albala
Journal:  Stroke       Date:  2020-10-26       Impact factor: 7.914

5.  Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans.

Authors:  Margaret Infeld; Kevin A Friede; Tan Ru San; Holly J Knickerbocker; Geoffrey S Ginsburg; Thomas L Ortel; Deepak Voora
Journal:  J Thromb Thrombolysis       Date:  2020-11-06       Impact factor: 2.300

6.  The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled Trial.

Authors:  Carolyn H Still; Chris Burant; Shirley Moore; Doug Einstadter; Cheryl Killion; Charles Modlin; Sophia Sundararajan; John D Thornton; Jackson T Wright; Martha Sajatovic
Journal:  J Multidiscip Healthc       Date:  2021-02-23

7.  The Effects of Body Mass Index on In-hospital mortality following first ischemic or hemorrhagic stroke events: Does the "obesity paradox" apply?

Authors:  Kevin J Kinter; Robert Alfaro; Christopher Kinter; Lucas Suder; Zachary Davis; Pura Rodriguez; Juan Gabriel Ruiz; Juan Carlos Zevallos; Adel Elkbuli
Journal:  Ann Med Surg (Lond)       Date:  2021-09-08

8.  Cilostazol for secondary stroke prevention: systematic review and meta-analysis.

Authors:  Choon Han Tan; Andrew Gr Wu; Ching-Hui Sia; Aloysius St Leow; Bernard Pl Chan; Vijay Kumar Sharma; Leonard Ll Yeo; Benjamin Yq Tan
Journal:  Stroke Vasc Neurol       Date:  2021-02-04

9.  Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial.

Authors:  Hooman Kamel; Cenai Zhang; Dawn O Kleindorfer; Emily B Levitan; Virginia J Howard; George Howard; Elsayed Z Soliman; S Claiborne Johnston
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.